Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Tecartus Market Report 2025

Tecartus Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Mantle Cell Lymphoma (MCL), Acute Lymphoblastic Leukemia (ALL), Other Hematologic Cancers), By Distribution Channel (Hospitals, Specialty Pharmacies), By End User (Pediatric, Adult, Geriatric)

Tecartus Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Tecartus Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Tecartus Market Definition

Tecartus is a CAR-T cell therapy used to treat certain blood cancers, such as relapsed or refractory Mantle Cell Lymphoma (MCL) and B-cell acute lymphoblastic leukemia (ALL). It works by reprogramming a patient’s T-cells to target and destroy cancer cells, offering a personalized and targeted approach to treatment.

The main types of indications for tecartus include mantle cell lymphoma (MCL), acute lymphoblastic leukemia (ALL), and other hematologic cancers. Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin lymphoma that affects the lymphatic system, and tecartus is used for patients with relapsed or refractory MCL to improve survival rates and reduce symptoms. The distribution channels include hospitals and specialty pharmacies for end users such as pediatric, adult, and geriatric

Tecartus Market Segmentation

The tecartus market covered in this report is segmented –

1) By Indication: Mantle Cell Lymphoma (MCL); Acute Lymphoblastic Leukemia (ALL); Other Hematologic Cancers

2) By Distribution Channel: Hospitals; Specialty Pharmacies

3) By End User: Pediatric; Adult; Geriatric

Tecartus Market Size and growth rate 2025 to 2029: Graph

Tecartus Market Size 2025 And Growth Rate

The tecartus market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rise in prevalence of hematologic cancers, increased acceptance of personalized medicine, regulatory approvals from health authorities like the FDA, high patient demand for innovative therapies, and improvements in diagnostic techniques for blood cancers.

Tecartus Market Growth Forecast

The tecartus market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing global incidence of hematologic cancers, rising adoption of Car T-cell therapies, expanding healthcare infrastructure in emerging markets, rising healthcare awareness and education, and expansion of reimbursement policies for Car T-cell therapies. Major trends in the forecast period include increasing collaboration between biotech and pharmaceutical companies, the development of next-generation Car T-cell therapies, the integration of artificial intelligence in treatment optimization, advancements in Car T-cell therapy technologies, and advancements in gene editing technologies.

Book your 30 minutes free consultation with our research experts

Contact Us

Tecartus Market Driver: Rising Prevalence Of Hematologic Cancers Fuels Growth Of The Market

The rising prevalence of hematologic cancers is anticipated to drive the tecartus market going forward. Hematologic cancers refer to malignancies originating in the blood-forming tissues, such as bone marrow and lymphatic systems, and are characterized by abnormal cell growth and impaired blood cell function. The prevalence of hematologic cancers is increasing due to factors such as limited treatment options, especially in relapsed or refractory cases, and the growing incidence of these malignancies globally. Tecartus is essential for addressing hematologic cancers by offering an innovative treatment to improve patient outcomes. For instance, in January 2024, according to a report published by the American Cancer Society, a US-based nonprofit cancer advocacy organization, the estimates for acute lymphoblastic leukemia (ALL) ( a type of hematologic cancer) in the United States for 2024 include approximately 6,550 new cases (3,590 in males and 2,960 in females) compared to 6540 in 2023. Therefore, the growing prevalence of hematologic cancers will drive the tecartus market.

Tecartus Market Driver: Growing Healthcare Expenditure Drives Growth In The Market

The growing healthcare expenditure is expected to propel the growth of the tecartus market going forward. Healthcare expenditure is the total financial resources spent on healthcare services by governments, businesses, and individuals, including medical treatments, hospital care, medications, and public health initiatives. The increase in healthcare expenditure is due to advancements in medical technology, increasing healthcare needs, and an increasing emphasis on quality patient care, leading to higher investments globally. The increase in healthcare expenditure facilitates the establishment of advanced treatment centers capable of delivering CAR-T therapies, including the complex manufacturing and administration process required for tecartus. For instance, in December 2023, according to the Centers for Medicare and Medicaid Services, a US-based federal agency, in 2022, United States healthcare spending rose by 4.1%, totaling $4.5 trillion, outpacing the 3.2% increase seen in 2021. Therefore, growing healthcare expenditure drives growth in the tecartus market.

Global Tecartus Market Major Players

Major companies operating in the tecartus market are Gilead Sciences Inc.

Global Tecartus Market Trend: Driving Advances In Oncology With Broader Approvals

The key trend in the tecartus market is adopting and approving CAR T-cell therapies for broader indications, such as relapsed or refractory B-cell precursor ALL, to enhance drugs positioning as a reliable, effective, and innovative treatment in the oncology industry. Tecartus therapy, approved for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), offers high remission rates and durable responses. For instance, in September 2022, Kite Pharma, Inc., a US-based biotechnology company, received the European Commission approval for Tecartus (brexucabtagene autoleucel) for adults aged 26 and above with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The approval is based on the ZUMA-3 study, where 71% of evaluable patients achieved complete remission (CR) or CR with incomplete hematological recovery (CRi), with a median overall survival of over two years and nearly four years for responders. Safety results were consistent with the known profile, with Grade 3+ cytokine release syndrome in 25% and neurologic events in 32%, both manageable.

Regional Analysis For The Global Tecartus Market

North America was the largest region in the tecartus market in 2024. The regions covered in the tecartus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tecartus market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Tecartus Market?

The tecartus market consists of sales of autologous cell therapy (personalized treatment), infusion solution, cryopreserved formulation, and viral vectors for cell modification. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tecartus Industry?

The tecartus market research report is one of a series of new reports from The Business Research Company that provides tecartus market statistics, including tecartus industry global market size, regional shares, competitors with a tecartus market share, detailed tecartus market segments, market trends and opportunities, and any further data you may need to thrive in the tecartus industry. This tecartus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tecartus Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The tecartus market covered in this report is segmented –
1) By Indication: Mantle Cell Lymphoma (MCL); Acute Lymphoblastic Leukemia (ALL); Other Hematologic Cancers
2) By Distribution Channel: Hospitals; Specialty Pharmacies
3) By End User: Pediatric; Adult; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Gilead Sciences Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Tecartus Market Characteristics

    3. Tecartus Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Tecartus Market Trends And Strategies

    5. Tecartus Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Tecartus Growth Analysis And Strategic Analysis Framework

    6.1. Global Tecartus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Tecartus Market Growth Rate Analysis

    6.4. Global Tecartus Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Tecartus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Tecartus Total Addressable Market (TAM)

    7. Global Tecartus Pricing Analysis & Forecasts

    8. Tecartus Market Segmentation

    8.1. Global Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Mantle Cell Lymphoma (MCL)

    Acute Lymphoblastic Leukemia (ALL)

    Other Hematologic Cancers

    8.2. Global Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Specialty Pharmacies

    8.3. Global Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Pediatric

    Adult

    Geriatric

    9. Global Tecartus Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Tecartus Market Regional And Country Analysis

    10.1. Global Tecartus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Tecartus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Tecartus Market

    11.1. Asia-Pacific Tecartus Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Tecartus Market

    12.1. China Tecartus Market Overview

    12.2. China Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Tecartus Market

    13.1. India Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Tecartus Market

    14.1. Japan Tecartus Market Overview

    14.2. Japan Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Tecartus Market

    15.1. Australia Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Tecartus Market

    16.1. South Korea Tecartus Market Overview

    16.2. South Korea Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Tecartus Market

    17.1. Western Europe Tecartus Market Overview

    17.2. Western Europe Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Tecartus Market

    18.1. UK Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Tecartus Market

    19.1. Germany Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Tecartus Market

    20.1. France Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Tecartus Market

    21.1. Eastern Europe Tecartus Market Overview

    21.2. Eastern Europe Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Tecartus Market

    22.1. North America Tecartus Market Overview

    22.2. North America Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Tecartus Market

    23.1. USA Tecartus Market Overview

    23.2. USA Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Tecartus Market

    24.1. Canada Tecartus Market Overview

    24.2. Canada Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Tecartus Market

    25.1. South America Tecartus Market Overview

    25.2. South America Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Tecartus Market

    26.1. Middle East Tecartus Market Overview

    26.2. Middle East Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Tecartus Market

    27.1. Africa Tecartus Market Overview

    27.2. Africa Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Tecartus Market Competitive Landscape And Company Profiles

    28.1. Tecartus Market Competitive Landscape

    28.2. Tecartus Market Company Profiles

    28.2.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Tecartus Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Tecartus Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Tecartus Market

    32. Recent Developments In The Tecartus Market

    33. Tecartus Market High Potential Countries, Segments and Strategies

    33.1 Tecartus Market In 2029 - Countries Offering Most New Opportunities

    33.2 Tecartus Market In 2029 - Segments Offering Most New Opportunities

    33.3 Tecartus Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Tecartus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Tecartus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Gilead Sciences Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Tecartus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Tecartus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Tecartus Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Tecartus Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Tecartus Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Gilead Sciences Inc. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Read More

Cell Therapy Technologies Market 2023 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End User (Life Science Companies, Research Institutes And Cell Banks), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Stem Cell Therapy Market 2022 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders), By End-Users (Hospitals And Clinics, Research Centers), And By Region, Opportunities And Strategies – Global Forecast To 2031

View Report

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Stem Cell Therapy Global Market Report 2025 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others), By End-Users (Hospitals And Clinics, Research Centers, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End User (Life Science Companies, Research Institutes And Cell Banks) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autologous Cell Therapy Global Market Report 2025 – By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications), By End User (Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

GMP Cell Therapy Consumables Global Market Report 2025 – By Product (Kits, Reagents or Molecular biology reagents, Growth Factors or Cytokines and Interleukins, Other Products), By Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies), By Process (Cell Collection And Characterization or Sorting and Separation, Cell Culture and Expansion or Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution or Handling, Process Monitoring and Control or Readministration or Quality Assurance, Other Processes), By End-Use (Clinical, Commercial, Research) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Tecartus market?

Tecartus is a CAR-T cell therapy used to treat certain blood cancers, such as relapsed or refractory mantle cell lymphoma (MCL) and B-cell acute lymphoblastic leukemia (ALL). It works by reprogramming a patient’s T-cells to target and destroy cancer cells, offering a personalized and targeted approach to treatment. For further insights on the Tecartus market, request a sample here

How will the Tecartus market drivers and restraints affect the market dynamics? What forces will shape the Tecartus industry going forward?

The Tecartus market major growth driver - Rising Prevalence Of Hematologic Cancers Fuels Growth Of The Market. For further insights on the Tecartus market, request a sample here

What is the forecast market size or the forecast market value of the Tecartus market?

The Tecartus market size has grown strongly in recent years. The tecartus market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rise in prevalence of hematologic cancers, increased acceptance of personalized medicine, regulatory approvals from health authorities like the FDA, high patient demand for innovative therapies, and improvements in diagnostic techniques for blood cancers. The tecartus market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing global incidence of hematologic cancers, rising adoption of Car T-cell therapies, expanding healthcare infrastructure in emerging markets, rising healthcare awareness and education, and expansion of reimbursement policies for Car T-cell therapies. Major trends in the forecast period include increasing collaboration between biotech and pharmaceutical companies, the development of next-generation Car T-cell therapies, the integration of artificial intelligence in treatment optimization, advancements in Car T-cell therapy technologies, and advancements in gene editing technologies. For further insights on the Tecartus market, request a sample here

How is the Tecartus market segmented?

The tecartus market covered in this report is segmented –
1) By Indication: Mantle Cell Lymphoma (MCL); Acute Lymphoblastic Leukemia (ALL); Other Hematologic Cancers
2) By Distribution Channel: Hospitals; Specialty Pharmacies
3) By End User: Pediatric; Adult; Geriatric For further insights on the Tecartus market, request a sample here

Which region has the largest share of the Tecartus market? What are the other regions covered in the report?

North America was the largest region in the tecartus market in 2024. The regions covered in the tecartus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Tecartus market, request a sample here.

Who are the major players in the Tecartus market?

Major companies operating in the tecartus market are Gilead Sciences Inc. . For further insights on the Tecartus market, request a sample here.

What are the key trends in the Tecartus market?

Major trends in the Tecartus market include Driving Advances In Oncology With Broader Approvals. For further insights on the Tecartus market, request a sample here.

What are the major opportunities in the Tecartus market? What are the strategies for the Tecartus market?

For detailed insights on the major opportunities and strategies in the Tecartus market, request a sample here.

How does the Tecartus market relate to the overall economy and other similar markets?

For detailed insights on Tecartus's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Tecartus industry?

For detailed insights on the mergers and acquisitions in the Tecartus industry, request a sample here.

What are the key dynamics influencing the Tecartus market growth? SWOT analysis of the Tecartus market.

For detailed insights on the key dynamics influencing the Tecartus market growth and SWOT analysis of the Tecartus industry, request a sample here.